Annual CFO
-$11.56 M
-$10.64 M-1154.83%
31 December 2023
Summary:
Trinity Biotech annual cash flow from operations is currently -$11.56 million, with the most recent change of -$10.64 million (-1154.83%) on 31 December 2023. During the last 3 years, it has fallen by -$35.31 million (-148.65%). TRIB annual CFO is now -148.65% below its all-time high of $23.75 million, reached on 31 December 2020.TRIB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$3.62 M
-$2.52 M-229.36%
30 September 2024
Summary:
Trinity Biotech quarterly cash flow from operations is currently -$3.62 million, with the most recent change of -$2.52 million (-229.36%) on 30 September 2024. Over the past year, it has increased by +$1.04 million (+22.32%). TRIB quarterly CFO is now -129.04% below its all-time high of $12.47 million, reached on 31 December 2020.TRIB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$7.30 M
+$1.04 M+12.48%
30 September 2024
Summary:
Trinity Biotech TTM cash flow from operations is currently -$7.30 million, with the most recent change of +$1.04 million (+12.48%) on 30 September 2024. Over the past year, it has increased by +$2.67 million (+26.77%). TRIB TTM CFO is now -123.37% below its all-time high of $31.23 million, reached on 31 March 2021.TRIB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1154.8% | +22.3% | +26.8% |
| 3 y3 years | -148.7% | -313.5% | -134.1% |
| 5 y5 years | -259.9% | -178.2% | -166.2% |
TRIB Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -148.7% | at low | -183.7% | +22.3% | -134.1% | +37.4% |
| 5 y | 5 years | -148.7% | at low | -129.0% | +22.3% | -123.4% | +37.4% |
| alltime | all time | -148.7% | at low | -129.0% | +22.3% | -123.4% | +37.4% |
Trinity Biotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.62 M(+229.4%) | -$7.30 M(-12.5%) |
| June 2024 | - | -$1.10 M(-61.0%) | -$8.34 M(-28.5%) |
| Mar 2024 | - | -$2.82 M(-1264.9%) | -$11.66 M(+0.9%) |
| Dec 2023 | -$11.56 M(+1154.8%) | $242.00 K(-105.2%) | -$11.56 M(+15.9%) |
| Sept 2023 | - | -$4.66 M(+5.6%) | -$9.97 M(+115.4%) |
| June 2023 | - | -$4.42 M(+62.5%) | -$4.63 M(+115.7%) |
| Mar 2023 | - | -$2.72 M(-248.4%) | -$2.15 M(+133.0%) |
| Dec 2022 | -$921.00 K(-107.0%) | $1.83 M(+170.9%) | -$921.00 K(-158.4%) |
| Sept 2022 | - | $676.00 K(-134.9%) | $1.58 M(-39.3%) |
| June 2022 | - | -$1.94 M(+29.6%) | $2.60 M(-54.1%) |
| Mar 2022 | - | -$1.49 M(-134.5%) | $5.66 M(-57.2%) |
| Dec 2021 | $13.24 M(-44.3%) | $4.33 M(+155.2%) | $13.24 M(-38.1%) |
| Sept 2021 | - | $1.70 M(+50.4%) | $21.38 M(-20.0%) |
| June 2021 | - | $1.13 M(-81.5%) | $26.72 M(-14.5%) |
| Mar 2021 | - | $6.08 M(-51.2%) | $31.23 M(+31.5%) |
| Dec 2020 | $23.75 M(+338.5%) | $12.47 M(+77.4%) | $23.75 M(+210.8%) |
| Sept 2020 | - | $7.03 M(+24.5%) | $7.64 M(+45.7%) |
| June 2020 | - | $5.65 M(-504.4%) | $5.25 M(+15.3%) |
| Mar 2020 | - | -$1.40 M(-61.6%) | $4.55 M(-16.0%) |
| Dec 2019 | $5.42 M(-25.1%) | -$3.64 M(-178.5%) | $5.42 M(-50.9%) |
| Sept 2019 | - | $4.63 M(-6.4%) | $11.03 M(+18.2%) |
| June 2019 | - | $4.95 M(-1037.3%) | $9.33 M(+57.7%) |
| Mar 2019 | - | -$528.00 K(-126.7%) | $5.92 M(-18.1%) |
| Dec 2018 | $7.23 M(-21.8%) | $1.98 M(-32.6%) | $7.23 M(+6.9%) |
| Sept 2018 | - | $2.93 M(+91.3%) | $6.76 M(-14.4%) |
| June 2018 | - | $1.53 M(+95.9%) | $7.90 M(-19.4%) |
| Mar 2018 | - | $783.00 K(-48.1%) | $9.80 M(+5.9%) |
| Dec 2017 | $9.25 M(-9.6%) | $1.51 M(-62.9%) | $9.25 M(+5.7%) |
| Sept 2017 | - | $4.07 M(+18.5%) | $8.75 M(-13.1%) |
| June 2017 | - | $3.43 M(+1355.1%) | $10.07 M(+14.0%) |
| Mar 2017 | - | $236.00 K(-76.6%) | $8.83 M(-13.7%) |
| Dec 2016 | $10.23 M(-22.3%) | $1.01 M(-81.2%) | $10.23 M(-40.0%) |
| Sept 2016 | - | $5.39 M(+145.0%) | $17.04 M(+20.7%) |
| June 2016 | - | $2.20 M(+34.5%) | $14.12 M(+9.2%) |
| Mar 2016 | - | $1.63 M(-79.1%) | $12.92 M(-1.8%) |
| Dec 2015 | $13.16 M(-18.1%) | $7.82 M(+217.4%) | $13.16 M(-7.6%) |
| Sept 2015 | - | $2.46 M(+145.7%) | $14.23 M(-16.2%) |
| June 2015 | - | $1.00 M(-46.3%) | $16.98 M(-1.0%) |
| Mar 2015 | - | $1.87 M(-79.0%) | $17.14 M(+6.8%) |
| Dec 2014 | $16.06 M | $8.90 M(+70.9%) | $16.06 M(+111.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $5.21 M(+344.7%) | $7.59 M(+31.1%) |
| June 2014 | - | $1.17 M(+49.6%) | $5.79 M(-18.2%) |
| Mar 2014 | - | $783.00 K(+81.7%) | $7.08 M(-24.3%) |
| Dec 2013 | $9.36 M(-53.1%) | $431.00 K(-87.3%) | $9.36 M(-36.8%) |
| Sept 2013 | - | $3.41 M(+38.4%) | $14.81 M(-12.1%) |
| June 2013 | - | $2.46 M(-19.5%) | $16.84 M(-12.5%) |
| Mar 2013 | - | $3.06 M(-48.0%) | $19.25 M(-3.6%) |
| Dec 2012 | $19.96 M(-2.4%) | $5.88 M(+8.0%) | $19.96 M(+8.9%) |
| Sept 2012 | - | $5.45 M(+11.9%) | $18.34 M(+1.9%) |
| June 2012 | - | $4.87 M(+29.1%) | $18.00 M(-1.3%) |
| Mar 2012 | - | $3.77 M(-11.5%) | $18.23 M(-10.9%) |
| Dec 2011 | $20.46 M(-11.3%) | $4.26 M(-16.7%) | $20.46 M(-13.2%) |
| Sept 2011 | - | $5.11 M(+0.3%) | $23.56 M(-0.7%) |
| June 2011 | - | $5.10 M(-14.9%) | $23.72 M(-1.8%) |
| Mar 2011 | - | $5.99 M(-18.6%) | $24.16 M(+4.7%) |
| Dec 2010 | $23.07 M(+56.6%) | $7.36 M(+39.5%) | $23.07 M(+12.1%) |
| Sept 2010 | - | $5.28 M(-4.6%) | $20.58 M(+8.2%) |
| June 2010 | - | $5.53 M(+12.7%) | $19.03 M(+8.2%) |
| Mar 2010 | - | $4.91 M(+0.7%) | $17.59 M(+19.4%) |
| Dec 2009 | $14.73 M(+37.3%) | $4.87 M(+30.9%) | $14.73 M(+49.4%) |
| Sept 2009 | - | $3.72 M(-9.0%) | $9.86 M(+60.6%) |
| June 2009 | - | $4.09 M(+99.2%) | $6.14 M(+21.8%) |
| Mar 2009 | - | $2.05 M(-31.4%) | $5.04 M(+20.9%) |
| Dec 2008 | $10.73 M(-30.1%) | - | - |
| June 2008 | - | $2.99 M(+153.2%) | $4.17 M(+253.2%) |
| Mar 2008 | - | $1.18 M | $1.18 M |
| Dec 2007 | $15.35 M(+108.3%) | - | - |
| Dec 2006 | $7.37 M(-20.0%) | - | - |
| Dec 2005 | $9.21 M(+1806.6%) | - | - |
| Dec 2004 | $483.00 K(-86.6%) | - | - |
| Dec 2003 | $3.60 M(+42.5%) | - | - |
| Dec 2002 | $2.53 M(-50.9%) | - | - |
| Dec 2001 | $5.15 M(+70.5%) | - | - |
| Dec 2000 | $3.02 M(-20.9%) | - | - |
| Dec 1999 | $3.82 M(-482.2%) | - | - |
| Dec 1998 | -$1.00 M(-28.6%) | - | - |
| Dec 1997 | -$1.40 M(-61.1%) | - | - |
| Dec 1996 | -$3.60 M(+350.0%) | - | - |
| Dec 1995 | -$800.00 K(-74.2%) | - | - |
| Dec 1994 | -$3.10 M(+29.2%) | - | - |
| Feb 1994 | -$2.40 M | - | - |
FAQ
- What is Trinity Biotech annual cash flow from operations?
- What is the all time high annual CFO for Trinity Biotech?
- What is Trinity Biotech annual CFO year-on-year change?
- What is Trinity Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for Trinity Biotech?
- What is Trinity Biotech quarterly CFO year-on-year change?
- What is Trinity Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for Trinity Biotech?
- What is Trinity Biotech TTM CFO year-on-year change?
What is Trinity Biotech annual cash flow from operations?
The current annual CFO of TRIB is -$11.56 M
What is the all time high annual CFO for Trinity Biotech?
Trinity Biotech all-time high annual cash flow from operations is $23.75 M
What is Trinity Biotech annual CFO year-on-year change?
Over the past year, TRIB annual cash flow from operations has changed by -$10.64 M (-1154.83%)
What is Trinity Biotech quarterly cash flow from operations?
The current quarterly CFO of TRIB is -$3.62 M
What is the all time high quarterly CFO for Trinity Biotech?
Trinity Biotech all-time high quarterly cash flow from operations is $12.47 M
What is Trinity Biotech quarterly CFO year-on-year change?
Over the past year, TRIB quarterly cash flow from operations has changed by +$1.04 M (+22.32%)
What is Trinity Biotech TTM cash flow from operations?
The current TTM CFO of TRIB is -$7.30 M
What is the all time high TTM CFO for Trinity Biotech?
Trinity Biotech all-time high TTM cash flow from operations is $31.23 M
What is Trinity Biotech TTM CFO year-on-year change?
Over the past year, TRIB TTM cash flow from operations has changed by +$2.67 M (+26.77%)